BUSINESS● LOW2h ago · Oct 28, 2026, 3:57 PM
Sellas falls as REGAL trial nears final analysis
Seeking Alpha Tech · global
Sellas stock has declined as its REGAL trial approaches final analysis. This suggests investor reaction to anticipated results from a clinical trial.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS5m agoTanger Med, CDG, ONCF… In Morocco, the good and bad performers of the public sectorJeune AfriqueBUSINESS37m agoFidelity Bank Plc redeems $400m eurobond at maturityPremium Times